Back to Search
Start Over
Individualized strategy for clopidogrel suspension in patients undergoing off-pump coronary surgery for acute coronary syndrome: A case-control study
- Source :
- The Journal of Thoracic and Cardiovascular Surgery. 148:1299-1306
- Publication Year :
- 2014
- Publisher :
- Elsevier BV, 2014.
-
Abstract
- Objective: An increasing number of patients presenting for urgent coronary surgery have been exposed to clopidogrel, which constitutes a risk of bleeding and related events. Based on the wide variability in clopidogrel response and platelet function recovery after cessation, we evaluated the role of point-of-care platelet function testing to define the optimal time for off-pump coronary artery bypass graft (CABG) surgery in a case-control study. Methods: Three equally matched groups (300 patients in total) undergoing isolated off-pump CABG for acute coronary syndrome were compared. Group A were treated with clopidogrel and prospectively underwent a strategy guided by platelet function testing. Outcomes were compared with 2 propensity score matched groups: group B underwent CABG after the currently recommended 5 days without clopidogrel; group C were never exposed to clopidogrel. Results: Patients in group A had reduced postoperative bleeding compared with those in group B (523 ± 202 mL vs 851 ± 605 mL; P < .001) and a lower number of units packed red blood cells (PRBCs) transfused during the postoperative hospital stay (1.2 ± 1.6 units vs 1.9 ± 1.8 units; P = .004). Postoperative bleeding and the number of units of PRBCs transfused were similar in group A and group C. There was no difference in blood-derived products and platelet consumption, mortality, or the need for reoperation among the groups. Patients in group A waited 3.6 ± 1.7 days for surgery. The strategy used for group A saved 280 days of hospital stay in total. Conclusions: The strategy guided by platelet function testing for off-pump CABG offers improved guidance for optimal timing of CABG in patients treated with clopidogrel. This strategy significantly reduces postoperative bleeding and blood consumption, and has a shorter waiting time for surgery than current clinical practice. © 2014 The American Association for Thoracic Surgery.
- Subjects :
- Pulmonary and Respiratory Medicine
medicine.medical_specialty
Acute coronary syndrome
medicine.diagnostic_test
business.industry
medicine.medical_treatment
Activated clotting time
Percutaneous coronary intervention
Odds ratio
medicine.disease
Clopidogrel
Surgery
Conventional PCI
Medicine
cardiovascular diseases
Fresh frozen plasma
Cardiology and Cardiovascular Medicine
Packed red blood cells
business
medicine.drug
Subjects
Details
- ISSN :
- 00225223
- Volume :
- 148
- Database :
- OpenAIRE
- Journal :
- The Journal of Thoracic and Cardiovascular Surgery
- Accession number :
- edsair.doi.dedup.....d14b7b726f12bdd1fbd03b281f2c9f8e